Gala Pharmaceutical Inc. Operating Income
Gala Pharmaceutical Inc. reported Operating Income of -$259.83 thousand for the 3-month period ending 2015-02-28, per its 10-Q filed 2015-04-22.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2015-04-22
- Gala Pharmaceutical Inc. operating income (loss) for the quarter ending 2015-02-28 was -$259.83K.
- Gala Pharmaceutical Inc. operating income (loss) for the quarter ending 2014-11-30 was -$38.35K.
- Gala Pharmaceutical Inc. operating income (loss) for the quarter ending 2014-08-31 was -$36.99K.
- Gala Pharmaceutical Inc. operating income (loss) for the quarter ending 2014-05-31 was -$5.10K.
- Gala Pharmaceutical Inc. operating income (loss) for fiscal 2014 was -$88.90K.
- Gala Pharmaceutical Inc. operating income (loss) for fiscal 2013 was -$35.99K.
- Gala Pharmaceutical Inc. operating income (loss) for fiscal 2012 was -$52.14K.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month | Operating Income (Loss) 45 month | Operating Income (Loss) 48 month | Operating Income (Loss) 51 month |
|---|---|---|---|---|---|---|---|
| 2015-02-28 | -$259.83K 10-Q · filed 2015-04-22 | -$298.18K derived: sum of 2 quarters · filed 2015-04-22 | -$335.17K derived: sum of 3 quarters · filed 2015-04-22 | -$340.27K derived: sum of 4 quarters · filed 2015-04-22 | |||
| 2014-11-30 | -$38.35K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | -$75.34K derived: sum of 2 quarters · filed 2015-03-13 | -$80.44K derived: sum of 3 quarters · filed 2015-03-13 | -$88.90K 10-K · filed 2015-03-13 | |||
| 2014-08-31 | -$36.99K 10-Q · filed 2014-10-20 | -$42.09K derived: sum of 2 quarters · filed 2014-10-20 | -$50.55K 10-Q · filed 2014-10-20 | -$62.35K derived: sum of 4 quarters · filed 2015-04-22 | |||
| 2014-05-31 | -$5.10K 10-Q · filed 2014-07-18 | -$13.56K 10-Q · filed 2014-07-18 | -$25.36K derived: sum of 3 quarters · filed 2015-04-22 | -$31.02K derived: sum of 4 quarters · filed 2015-04-22 | -$121.76K 10-Q · filed 2014-07-18 | ||
| 2014-02-28 | -$8.46K 10-Q · filed 2015-04-22 | -$20.27K derived: sum of 2 quarters · filed 2015-04-22 | -$25.91K derived: sum of 3 quarters · filed 2015-04-22 | -$34.34K derived: sum of 4 quarters · filed 2015-04-22 | -$116.66K 10-Q · filed 2014-04-28 | ||
| 2013-11-30 | -$11.80K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | -$17.45K derived: sum of 2 quarters · filed 2015-03-13 | -$25.88K derived: sum of 3 quarters · filed 2015-03-13 | -$35.99K 10-K · filed 2015-03-13 | -$108.20K 10-K · filed 2014-04-18 | ||
| 2013-08-31 | -$5.65K 10-Q · filed 2014-10-20 | -$14.08K derived: sum of 2 quarters · filed 2014-10-20 | -$24.19K 10-Q · filed 2014-10-20 | ||||
| 2013-05-31 | -$8.43K 10-Q · filed 2014-07-18 | -$18.54K 10-Q · filed 2014-07-18 | |||||
| 2013-02-28 | -$10.11K 10-Q · filed 2014-04-28 | ||||||
| 2012-11-30 | -$52.14K 10-K · filed 2014-04-18 |